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List of abbreviations 
7-NI = 7-nitroindazole NO = nitric oxide 
AA = arachidonic  acid  NOS = nitric oxide  synthase  
aCSF = arteficial cerebrospinal  fluid  OCT = optimal  cutting 
ATP = adenosine triphosphate  transformer 
cDNA = complementary OLM = outer  limiting 
deoxyribonucleic  acid  membrane 
COX = cyclooxygenase ONL = outer nuclear  layer  
COX-1 = cyclooxygenase-1 PL = outer plexiform layer 
COX-2 = cyclooxygenase-2 P = photoreceptor  layer  
DNA = deoxyribonucleic  acid  PBS = phosphate buffer 
eNOS = endothelial nitric oxide saline 
synthase PE = pigmentepithelium 
G = ganglion cells  PGD2  =  prostaglandin D2  
GFAP = glial  fibrillary  acidic protein PGE2  =  prostaglandin E2  
INL = inner nuclear  layer  PGF2a= prostaglandin  F2a 
ip = intraperitoneal PG = prostaglandin 
IPL = inner plexiform layer  PGH2  = prostaglandin H2  
IR = immunoreactive PGI2  = prostacyclin 
IR-ity = immunoreactivity PL = phospholipase 
iv = intravenous PLA2  = phospholipase A2  
mRNA = messenger ribonucleid  acid  RN-ase = ribonuclease 
NFL = nerve  fiber  layer  RPA = ribonuclease 
NGS = normal goat  serum protection  assay  
nNOS  =  neuronal nitric oxide Tx = thromboxane 
synthase TxA2  = thromboxane A2 
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Summary 
Hypoxia/ischemia is a relatively common occurrence during the perinatal period. After 
successful resuscitation, an episode of hypoxia/ischemia can be followed by secondary 
insults, including seizure activity, intracranial hemorrhage, brain edema and visual 
impairment. The factors involved in the secondary progression of the neuronal injury have not 
been fully elucidated. There is increasing evidence that the enhanced release and action of 
excitatory amino acids, free radical-mediated reactions and intracellular Ca2+  accumulation  
are neurochemical processes that contribute to the progression of ischemic brain damage. 
Recent data indicate that the enzymes that synthesize the prostanoids and nitric oxide are 
important components of the formation of free radicals, and thereby play essential roles in the 
development  of post-ischemic injuries. 
The aim of our studies was to characterize the cellular localization and expression of 
cyclooxygenase (COX), the rate-limiting enzyme for prostanoid synthesis in the newborn 
brain. Using immunohistochemical  techniques, we studied the distribution of prostaglandin H 
synthase -2 (cyclooxygenase-2 (COX-2)) and neuronal nitric oxide synthase (nNOS) in the 
piglet brain.  We also examined the effects of ischemia and asphyxia on the levels of 
prostaglandin H synthase-1 (COX-1) and COX-2.  However, the effects of ischemia on COX-
2 mRNA and protein levels were investigated in the retina and in various regions of the brain. 
Ischemia was induced by increasing intracranial pressure and lasted for  10 min.  In some 
animals, indomethacin or 7-nitroindazole was administered prior to ischemia to block COX or 
nNOS, respectively.  Tissues from the cerebral cortex, hippocampus, cerebellum and retina 
were removed and fixed and/or frozen after 1,2,4  and 8 hours of recovery from anoxic stress. 
Additionally, tissues were obtained from untreated animals or from time control  animals.  
Levels of mRNA and proteins were determined by using a ribonuclease protection assay and 
an immunohistochemical  approach,  respectively.  
In the tissues studied, only a few neurons were immunopositive for COX-1, and neither 
ischemia or asphyxia affected the COX-1 immunostaining at 8 hours after recovery. 
Likewise, the COX-1 mRNA level did not increase following anoxic stress.  In contrast, 
substantial COX-2 immunoreactivity  (COX-2 IR-ity) was present in the neurons and glial 
cells in the cerebral cortex, hippocampus, cerebellum and retina in the control animals. For 
3 
example, the neurons in cortical layers II/III, V and VI displayed very dense COX-2 IR-ity, 
whereas in the retina it was localized mainly to the outer limiting membrane and to the Miiller 
cells. 
Neurons, immunreactive for nNOS were limited in number and were widely dispersed  across  
all layers of the cortex; they did not form a definable pattern. In the cerebellum, COX-2 IR-ity 
was heavily represented in the Bergman glia, and nNOS was detected in the basket cells.  
The levels of COX-2 mRNA were undetectable in the control animals, but exhibited  dramatic  
increases in the brain and retina in the animals exposed to ischemia. The COX-2 mRNA level 
peaked by 2-4 hours after ischemia, and heightened COX-2 IR-ity was present at 6-8 hours: 
the COX-2 IR-ity was elevated in all layers of the retina, with the greatest increases in the 
photoreceptor  layer. Interestingly, asphyxia did not enhance the COX-2 mRNA or 
immunostaining.  Indomethacin pretreatment inhibited the increases in mRNA and protein for 
COX-2 after ischemia, while 7-nitroindazole had little effect on the increases in COX-2 
immunoreacti vity. 
We have demonstrated that COX-2 is the predominant isoform present in the piglet brain and 
retina. COX-2 IR-ity is widely represented  in the parietal and visual cortices, the 
hippocampus, the cerebellum and the retina. The distribution of nNOS is different from that 
of COX-2 in the neonatal brain. We have also shown that cerebral ischemia results in rapid 
increases in COX-2 IR-ity in all tissues investigated.  Since COX and NOS-derived 
metabolites are involved in hypoxic/ischemic injuries, we conclude that elevated protein 
levels may be crucial factors in the development  of secondary perinatal brain damage. 
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Introduction 
Disturbances in the fetal oxygen supply are common insults during the perinatal period. There 
has long been interest in determination of the relationship between an insufficient exchange of 
respiratory gases, an inappropriate blood supply to the brain in perinatal life and their 
neuropathology manifestations in surviving children (Vannucci,  1993).  Extensive research 
conducted in the past several years has led to a better understanding of the mechanisms 
involved in perinatal hypoxic/ischemic brain injury.  These studies have revealed that 
different pathogenetic mechanisms, such as a decreased blood flow autoregulation,  an altered 
cerebral metabolism, thrombosis, hemorrhage, the accumulation of toxic metabolites such as 
glutamate, an impaired intracellular Ca2+ turnover, the release of interleukins and 
prostaglandins (PG-s), Fe accumulation and the overproduction  of free radicals, are the major 
components of the neuronal impairment (Berger and Gamier, 2000).  It has also been clarified 
that the brain tissue injuries observed following ischemia have two major phases  (Vannucci,  
1993; Volpe,  1994). In the first, acute phase, the inappropriate oxygen supply has a direct 
effect on the cellular functions.  Minutes of severe ischemia affect specific populations of 
neurons where irreversible cellular injury is initiated (Siesjo and Siesjo,  1996).  Clinical and 
experimental data have also revealed that severe perinatal asphyxial injury is associated with a 
latent phase after reperfusion (Vannucci,  1993; Volpe,  1994).  The cerebral  energy 
metabolism recovers initially, but the EEG remains suppressed (Williams et al,  1992).  This  
period is followed by a secondary phase with seizures, cytotoxic edema, the accumulation of  
cytotoxins, and cerebral energy failure from 6 to  15 hours after birth. At this time, additional  
cell injuries can occur (Berger and Gamier,  1999).  
Studies from our own laboratories and other have shown that hypoxia, asphyxia and cerebral  
ischemia are associated with a prolonged cerebrovascular dysfunction (Bari et al.,  1996a,b,c).  
There is a strong suggestion that an incongruity between the cerebral oxygen supply and 
demand may be involved in the mechanisms leading to secondary brain injuries (Hossmann, 
1999). 
Like other parts of the central nervous system, the retina is vulnerable to ischemia/reperfusion 
injury (Bazan,  1989; Bazan and Allan,  1997). The principal damage to the retina is related to 
the direct effects of energy failure. Similarly as in the other brain regions, a delay in the onset 
of neuronal cell death also occurs following ischemia in the retina. Most studies on the 
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postischemic retina have reported that cell death is most pronounced  in the inner retina 
(Bazan,  1989; Hardy et al., 2000). Although the precise mechanisms of  ischemia-induced 
neuronal death are unknown, excitotoxicity triggered by the overactivation of glutamate 
receptors is considered to be a central component of postischemic necrosis in the nervous 
tissues, including the retina (Hardy et al., 2000). 
Ischemia is known to disrupt the cellular energy state, to acidify intra- and extracellular fluids 
and to cause the loss of ionic homeostasis. The primary event in all ischemic conditions is a 
deficient delivery  of oxygen to the mitochondria, leading to a compromised production of 
ATP and a deranged cellular energy metabolism. Energy failure is accompanied by a massive 
release of K+ from the cells, and by the uptake of Ca2+, Na2+ and  CI" (Hansen,  1985). Cerebral 
ischemia disrupts the tightly regulated events that control the production and accumulation of  
lipid messengers, such as free arachidonic acid (AA), diacylglycerol  and platelet  activating  
factor under physiological  conditions. A rapid activation of phospholipases (PL-s), and 
particularly  of PL A2, occurs at the onset of cerebral ischemia. Whereas pathways leading to 
PLA2 activation/release  are part of the normal neuronal function, a number of data indicate 
that an overproduction of PLA2-derived lipid derivatives is involved in neuronal  damage 
(Chemtob et al,  1993; Hall,  1997). In recent years, it has become evident that, even after the 
successful termination of cerebral ischemia, additional cellular damage occurs in the 
reperfusion period. The contributors to tissue damage include oxygen free radicals and H202, 
which have diverse, detrimental effects on the cellular functions (Floyd,  1997). Increasing 
evidence suggests that one of the most important components of ischemic injuries is the 
damage to the membrane lipids. 
Characterization  of the AA metabolism 
AA products such as prostaglandins, Tx-s, and  15-hydroxyeicosatetraenoic  acids are 
collectively referred to as eicosanoids. These products are involved in various physiological 
and pathological processes, including inflammation, and the modulation of immune responses  
or pain sensation. The regulation of eicosanoid production has become an area of intense 
study because these fatty acid metabolites affect multiple signaling pathways that modulate a 
wide range of cellular functions. The two major determinants of eicosanoid production are the 
availability of substrates and the presence of synthetic enzymes. The biosynthetic pathway for 
eicosanoids has multiple steps that are possible sites of regulation.  Several PL-s, which 
liberate AA from membrane phospholipids have been characterized. The PL-s have important  
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regulatory functions in eicosanoid production. AA can be metabolized  in three main pathways 
via the actions of oxidative enzymes such as cyclooxygenases (COX-s), lipoxygenases and 
cytochrome P-450 monooxygenases (Shimizu and Wolfe,  1990).  
The relative levels of various eicosanoids are determined by different synthetic enzymes that 
are under genetic control and are specific for the cell type and the physiological  conditions.  
The clearest example is the predominant production of prostacyclin by endothelial cells and of 
T X A 2  by platelets from the same precursor following the initial conversion of A A  (Vane and 
Botting,  1995).  
The various PG-s and Tx-s produced by COX are often collectively referred to as prostanoids. 
During the prostanoid production, the free AA is converted to PGG2 /H2 (PGH2) via 
prostaglandin G/H synthase, which is identical to COX (Busija,  1997).  Two isoforms of 
COX have been described. COX-1 appears to be the constitutive form. COX-1 mRNA and 
protein are present at relatively  stable levels in many tissues, but the prostanoid production of 
these tissues is variable. Recently a second, inducible form of COX (COX-2) has been 
identified. COX-2 expression is induced by a wide range of extra- and intracellular  stimuli,  
including interleukin-1, tumor necrosis factor or synaptic activity (DeWitt,  1991; Wu,  1996;  
Breder,  1997). The transcription of COX-2 mRNA does not require new protein  synthesis;  
therefore, it is an immediate early gene (O'Banion et al.,  1992). In addition to its expression at  
sites of inflammation, COX-2 is also expressed constitutively in a number of tissues, 
including the kidney and the brain. Detailed studies on adult animals have demonstrated that 
COX-1 is expressed in almost all structures in the central nervous system. In contrast,  COX-2 
is mainly expressed in the cortex, the hypothalamus and the hippocampus (Breder et al., 
1995). The brain COX-2 is identical to the non-nervous system COX-2 (Yamagata et al., 
1993). It is not yet clear what the specific roles of the two isoforms are in the central nervous 
system. However, it has been known for some time that prostanoids modulate activities  such 
as thermoregulation and sleep (Stitt,  1986; Hayaishi,  1988).  Prostanoids (PGD2, PGE2, 
PGF2 a, PGI2 and TxA2) are produced from PGH2 via specific enzymes. The regulation of 
COX-1 and COX-2 expression is therefore a key step in prostanoid production (Smith,  1992).  
PG-s act as modulators in several neurological  and cerebral hemodynamic functions (Busija, 
1996;  1997). During the perinatal period, the concentrations of PG-s in the blood and brain in 
the newborn are higher than those in the normal adult. It has been shown that the COX-2 
expression is increased in the brain cortex^pid periventricular  white matter of the newborn 
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and is the main source of high PG-s levels, such that the COX-2 activity accounts for ~80% of 
the total COX activity in the perinatal brain, whereas in the adult it is responsible for <10% of 
the total COX activity (Dumont et al.,  1998). The COX-1 expression in brain is unaltered 
during this developmental period. The prostanoids appear to play a particularly important role 
in the regulation of cerebral and the retinal circulation during the perinatal period (Zhu et al, 
1998). In this early stage of extra-uterine life, COX products have diverse effects on the 
cerebrovascular responses to a number of neurotransmitters (Busija,  1996). Inhibitors of COX 
activity reduce the basal cerebral blood flow, and minimize the dilator responses to arterial 
hypercapnia and hypotension. 
Neuronal excitation and an increased intracellular Ca  level, two stimuli that induce the 
expression of COX-2, are also important in the pathophysiology  of neuronal death in ischemia 
and a variety of neurodegenerative diseases (Rothman and Olney,  1986; Choi,  1997).  
The retina exhibits COX activity and synthesizes all major PG-s (Goh et al.,  1987, Hardy et 
al, 2000). PG synthesis in the retina can be activated by various conditions, such as exposure 
to high-intensity visible light (Birkle et al.,  1989; Hanna et al,  1997).  Further, PGE2  and 
PGF2aifa receptors are located on the retinal blood vessels, whereas PGE2 and PGD2  binding 
sites are present on various cell types, including photoreceptors,  and bipolar,  horizontal,  
ganglion and Miiller cells (Matsuo et al.,  1992; Kulkami and Payne,  1997; Hardy et al.,  1998).  
AA metabolites, possibly including prostanoids, also participate in the control of the retinal 
blood flow during hypo- and hypertension, but do not seem to control the basal  circulation  
(Chemtob et al.,  1991; Abran et al.,  1994;  1995).  Similarly, COX-derived metabolites would 
be expected to participate in the neuronal and vascular responses in the visual cortex 
(Yamagata et al.,  1993).  
In addition to the production of prostanoids, the conversion of AA results in the simultaneous 
production of the superoxide anion. This can have a particularly important role in the brain 
and retinal pathology during recovery from anoxic stresses such as ischemia or asphyxia, 
when large amounts of radicals are formed (al-Zadjali et al.,  1994; Hardy et al.,  1994; 2000). 
In the selectively vulnerable neurons, radical damage during reperfusion is aggravated by 
further factors, such as their deficiency in glutathione peroxidase or their high Fe content. 
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It is unclear whether the levels of constitutively expressed COX-2 are increased in the 
nonvascular tissues in the neonatal brain following anoxic stress.  Augmented levels of the 
COX isoforms in the neurons and glial cells following anoxic stress might lead to an 
enhanced capability for the production of the superoxide anion during delayed,  secondary 
insults, and thereby promote additional neuronal injury. Furthermore, recent data support the 
hypothesis that COX-2 activity leads directly to neuronal injury (Hara et al.,  1998).  
Nitric oxide in the nervous system of the neonate 
The three isoforms of nitric oxide synthase (NOS) include the Ca2+-independent isoform, 
which is expressed mainly in the macrophages, and the Ca2+-dependent isoforms, present in 
the endothelial cells (eNOS) and the neuronal tissues (nNOS). Nitric oxide (NO), formed via 
the nNOS, acts as a signal for the development  and shaping of neuronal cells and their  activity 
(Szabo,  1996), and also for the control of the blood supply to the brain in response to 
metabolic demands. More than 95% of all NOS activity in the brain is attributed to nNOS 
(Szabo,  1996).  
NOS displays a precise pattern of increased activity  in the nervous system during the perinatal 
period in various species, including rodents, pigs, cats and humans. These developmental  
changes in NOS activity immediately precede a period of maximal synaptogenesis, in which it 
has been implicated  (Mishra and Delivoria-Papadopoulos,  1999). Similar functions have been 
ascribed to COX-2. The mechanisms regulating this high NOS activity in the perinatal period 
are not well understood. Although a role has been suggested for estrogens, this contribution is  
only partial. A role for PG-s in regulating NOS activity under certain conditions has been 
proposed. It has been reported that COX inhibitors markedly inhibit NO production in the rat 
alveolar macrophages. This fact has led to the suggestion that the inhibition of PG synthesis  
results in an inhibition of NOS gene expression and in turn in a decreased NO synthesis.  
There is also evidence that the constitutive NOS (eNOS and nNOS) can potentially be 
induced by the PG-s (Salvemini et al.,  1993). Furthermore, the suggested role of estrogens in 
partially governing the NOS activity may be partly mediated by the PG-s, since estradiol can 
stimulate PG synthesis (MacRitchie et al,  1997).  
As NOS has the potential of being induced by the PG-s (Salvemini et al.,  1993), and both the 
PG levels and the NOS activity have been found to be high in the brain tissue of the perinate 
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(Mishra and Delivoria-Papadopoulos,  1999), a precise interplay can be hypothetized  between  
the PG-s and nNOS in the brain in the newborn can be. 
Cerebral  ischemia/reperfusion 
Cerebral hypoxia/ischemia during the perinatal period in humans is often followed by 
extensive brain damage. As in adults, the developing brain is subjected to  ischemia-induced  
injury, such as global necrosis, focal infarction, selective neuronal necrosis, and border zone 
infarction (i.e. in regions at the edge of the terminal blood supply). The major observations 
during investigations of brain injury by ischemia and reperfusion were as follows: 
1.  morphologic studies revealed that most of the structural damage occurs during 
reperfusion; 
2.  progressive hypoperfusion of the brain occurs during reperfusion; and 
3.  there is a prolonged suppression of protein synthesis (Berger and Gamier, 2000). 
Although most of the phenomena observed following brain ischemia have been known for 
decades, the understanding of the mechanisms involved in the damage and in the possible 
repair remains inadequate. The fact that cellular division and migration, neurite outgrowth, 
myelination and synapse formation occur during the perinatal period makes the developing 
brain particularly susceptible to anoxic stress.  The high-energy metabolism in the brain is 
fully dependent on the blood supply. During ischemia, a very rapid rundown of ATP occurs,  
which is accompanied by ionic shifts and Ca  -mediated enzymatic lipolysis. In the lack of a 
blood/oxygen supply, the brain ATP levels approach zero within minutes. Reperfusion results 
in oxidative metabolism of the AA released during ischemia, with the consequent  generation  
of the superoxide radical, the reduction and release of stored ions, and the excerbation of 
membrane damage by lipid peroxidation.  Since cellular damage is consistently  observed in 
the cerebral cortex, hippocampus,  and cerebellum, these brain regions are considered to be 
particularly vulnerable to anoxic stress (Vannucci,  1995).  
The molecular basis of the selective vulnerability of various brain structures, or even of 
various cell types within one region, is still an enigma. Depending on the severity of the 
damage induced by the ischemic insult and the properties of the afflicted neurons, cell death 
may occur rapidly, during a few hours, or slowly, over several days or months. Studies on 
overall postischemic protein synthesis activity demonstrate a general translation deficit. The 
lethally damaged neurons exhibit an irreversible translation block, whereas the protein 
synthesis in the surviving neuronal populations finally recovers completely. There is evidence 
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that the extent and duration of protein synthesis inhibition vary in the different regions of the 
brain. The regional differences in the prolonged inhibition of protein synthesis are correlated 
with morphological evidence of cellular injury (Wieloch et al.,  1997).  
Even though the protein synthesis in general appears to be suppressed, an increased  synthesis  
of specific proteins in the early phase of ischemia/reperfusion has been reported in both adults 
and neonates. Functional analysis of the early-expressed proteins has shown that some of 
them may be beneficial for cell survival (Koistinaho and Hokfelt,  1997). However, the early 
appearance of other enzymes could be detrimental (Gass et al.,  1997). The effect of 
ischemia/reperfusion on protein synthesis should therefore be considered an important step in 
the understanding of the development of cerebral injury after anoxic stress. 
To replicate the features of human ischemic injuries, various animal models have been 
investigated. The best animal model of neonatal hypoxic/ischemic brain injury is the one that 
most closely approximates to the damage found in human infants. However, both clinically 
and in animal models, the type of damage observed will depend on the maturity of the brain. 
Several species, including mice, rats, guinea pigs, rabbits, cats, dogs, piglets, sheep and 
monkeys, are used for studies of neonatal brain injuries (Raju, 1992). Detailed direct  
comparisons between species indicate that, during the first 2 weeks postpartum, the piglet 
brain displays developmental  and morphological similarities with that of human babies. 
(Buckley,  1986). The use of piglets to study the effects of cerebral ischemia/reperfusion 
therefore offers several advantages. In addition, since this species is widely used for 
investigations of cerebrovascular function, a considerable amount of information is available 
regarding the piglet physiology, pharmacology  and neural  electrophysiology.  
The purposes of our studies were as follows: 
1.  To characterize the distributions of COX-2 and nNOS in the neonatal brain. We focused 
on three particularly interesting regions: the cerebral cortex, the hippocampus and the 
cerebellum. These areas were chosen because they represent different stages of 
development in the neonatal brain and because of their susceptibility to damage after 
hypoxic/anoxic stress (Vannucci,  1993).  
2.  To characterize the effects of anoxic stress on the brain levels of COX-1 and COX-2 and 
to test the hypothesis that anoxic stress may increase the brain levels of COX-2, but not 
COX-1.  We focused on the responses in the parietal and visual cortices and the 
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hippocampus. We also examined the effects of two different kinds of anoxic stress,  10  
minutes of total ischemia or  10 minutes of whole-body  asphyxia.  
3.  To examine the regulation of COX-2 in the retina.  We tested the hypotheses that COX-2 
is constitutively  expressed in the retina, and that transient cerebral ischemia causes rapid 
increases in COX-2 levels.  
4.  To examine the effects of indomethacin pretreatment on the increases in COX-2 following 
ischemia.  Previous studies have shown that indomethacin pretreatment blocks  superoxide  
anion production (Armstead et. al.,  1988;  1989; Pourcyrous et al.,  1993) and preserves the 
cerebrovascular responsiveness (Bari et al.,  1996a, b) following cerebral  ischemia.  
5.  To characterize the effects of the inhibition of nNOS by 7-nitroindazole (7-NI) on 
theincreases in COX-2 following ischemia.  NO from nNOS has been suggested as a 
mediator of neuronal damage following ischemia (Huang et al.,  1994; Zhang et al.,  1996),  
but the role of nNOS in regulating the production of COX in the brain has not been 
examined. 
Materials and methods  
Surgical  procedure 
In this study,  1-7- day-old piglets of either sex with body weights of 0.9-1.4 kg were used. 
Anesthesia was induced with sodium thiopental  (30-40 mg/kg), followed by an intravenous 
(iv) injection of a-chloralose (75 mg/kg).  Supplemental doses of a-chloralose were given as 
needed to maintain a stable level of anesthesia. The animals were intubated via tracheotomy 
and artificially ventilated with room air.  The ventilation rate (~ 20 breaths/min) and tidal 
volume (~ 20 ml/kg) were adjusted to maintain the blood pH and gas values within the 
physiological ranges. In our study, these animals had baseline values within the normal limits  
for arterial pH (7.45±0.04), pC02  (32±4 mmHg), and p02  (95±4 mmHg) (n=69).  
Body temperature was maintained at 37-38 °C by a water- circulating heating pad.  Systemic  
arterial blood pressure was recorded via a catheter placed into the right femoral artery, which 
was connected to a pressure transducer.  The right femoral vein was catheterized for the 
administration of drugs and fluids.  The heads of the piglets were fixed in a stereotaxic frame. 
The scalp was incised and the connective tissue over the parietal bone was removed.  A  
craniotomy for a stainless steel-glass cranial window  19mm in diameter was made in the left 
parietal bone approximately  10mm rostral to the coronal suture.  The dura was exposed, cut 
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and reflected over the skull.  A cranial window with three needle ports was placed into the 
craniotomy, sealed with bone wax and cemented with cyanoacrylate ester and dental  acrylic.  
The closed window was filled with artificial cerebrospinal fluid (aCSF) warmed to 37 °C and 
equilibrated with 6% 0 2  and 6.5% C02  in N2.  The aCSF consisted of KC12.9,  MgCl21.4,  
CaCl21.2, NaCl  132, NaHC03  24.6, urea 6.7 and glucose 3.7 mmol/L. The diameters of 
thepial arterioles were measured by using a microscope  (Wild M36, Switzerland)  equipped 
with a video camera (Panasonic, Japan) and a video micro scaler  (IV-550, For-A Co. 
Newton, MA).  Following the surgical procedure, the cranial window was gently infused 
several times, with aCSF until a stable baseline was obtained. 
Hypoxic models used 
Asphyxia was achieved by turning off the ventilator and clamping the endotracheal tube. 
After 5 or  10 minutes of asphyxia, the tubing was unclasped and the animals were 
reventilated.  During resuscitation, iv epinephrine was given as needed to prevent asystole and 
3 ml/kg 4.2% NaHCC>3 solution was administered to counteract systemic acidosis.  
Cerebral ischemia-reperfusion injury was produced by elevation of the intracranial pressure to 
above the perfusion pressure, which was estimated via the arterial blood pressure.  During the 
surgical procedure,  a hollow brass bolt was placed in the left cranium without damaging the 
dura.  This bolt allowed the infusion of aCSF into the cranium, resulting in an increased 
intracranial pressure.  During ischemia, venous blood was withdrawn as necessary to maintain 
the mean arterial pressure near normal.  This was important to counteract the intense Cushing 
response. During ischemia, a complete cessation of blood flow to the cortex was evaluated by 
intravital microscopy. Lack of blood flow to the various regions other than the pial surface of 
the brain was verified by using a microsphere technique. During this procedure, colored 
microspheres  15 pm in diameter were injected into the left ventricle of the heart. A reference 
blood sample was collected from the femoral artery. Because of their rigidity, these 
microspheres were entrapped in the microcirculatory network, indicating the intensity  of  
tissue perfusion. Analysis of the number of microspheres detected in each region of the brain 
and the retina indicated that ischemia was widespread and total. As an example, prior to 
ischemia there were 216 ± 27 microspheres/g in the parietal cortex (n=4), whereas in the 
retina there were  176 ± 37 microspheres/g (n=4). During ischemia, the blood flow ceased in 
all the tissue samples investigated, as indicated by the lack of spheres detected  (<1 
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ml/min/lOOg). After  10 minutes of ischemia the infusion tube was clamped and the 
intracranial pressure was allowed to normalize. 
Experimental  protocols  
Anesthetized, instrumented piglets were divided into three groups: the asphyxia group (n=12),  
the ischemia group (n=39), and the time control group (n=35).  Some animals received 
indomethacin (5 mg/kg, iv) (n=7) or 7-NI (50 mg/kg, ip) (n=12) prior to ischemia. 
Indomethacin is an effective blocker of COX in the cerebral tissues of piglets (Armstead et 
al.,  1988; Pouryrous et al.,  1993, Bari et al.,  1996a), while 7-NI is an effective blocker of 
nNOS in piglets (Bari et al.,  1996b).  The time control animals were treated in the same way 
as the other two groups, except that they were not exposed to asphyxia or ischemia.  Animals 
were killed under anesthesia with KC1 at 1,2,4,  6, 8 and  12 hours after ischemia or asphyxia. 
Tissue samples were also obtained from untreated, euthanized (sodium thiopental,  150 mg/kg, 
ip) control animals (n=10). 
The brain was removed quickly and samples of the cerebral cortex, cerebellum,  hippocampus  
and retina were immersion-fixed in  10% neutral, buffered formalin for 15-24 hours or frozen 
by immersion in 2-methylbutane at -70 °C.  Frozen samples were stored at -60 °C.  Samples  
from the thalamus and the superior colliculus were also frozen. 
Immunohistochemistry 
The eyes were opened at the corneal-scleral border with a sharp blade and placed in neutral 
buffered formalin.  After fixation, the neural retina was removed with fine forceps, washed 
thoroughly in  10 mmol/L phosphate buffer/0.9% saline, pH 7.4 (PBS), embedded in optimal 
cutting transformer (OCT) and stored at -60  °C until cryostat sectioning.  Brain tissues were 
immersion-fixed overnight in the same fixative, washed in PBS and stored at 4°C until 
vibratome-sectioned. 
Sections of brain tissues (50 pm) and retina (8 pm) were stained free-floating by a three- step 
immunoperoxidase method.  
After washing in PBS, 50 pm vibratome sections were cut and collected in PBS containing 
0.1 mg/1 of thimerosal.  All washes and solutions were made in PBS unless otherwise  stated.  
The sections were incubated in 50 mmol/L NH4C1 for  1  hour, washed, and incubated in 0.3% 
Triton X-100 for another hour.  After washing, the sections were blocked in  10% normal  goat  
serum (NGS)/0.1% Tween 20 (NGS-T) for 4 hours.  Antibodies specific for COX-1 (Dr. 
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Steve Prescott,  Salt Lake City, UT) and COX-2 (Dr. A. W. Ford-Hutchinson, Merck Fross 
Center for Therapeutic Research, Pointe Claire, Quebec, Canada or PG 26, Oxford, Oxford, 
MI) were diluted  1:2000 and  1:10,000, respectively, in NGS-T and incubated with brain 
sections overnight at room temperature.  The use of either COX-2 antibody yielded virtually 
identical results.  For consistency, all of the photomicrographs of COX-2  immunostaining  
reflect the use of the antibody from Dr. Ford-Hutchinson.  After the rinsing of sections in 
NGS, endogenous peroxidase was blocked by incubating the sections in 3% H202/10% 
methanol for 30 minutes.  After washing, anti-COX-2 sections were incubated for 2 hours in 
biotinylated goat anti-rabbit IgG (Vector, Burlingame, CA), diluted  1:1000 in 2% NGS.  Anti-
COX-1 sections were treated similarly and were incubated for 2 hours in biotinylated  goat  
anti-mouse IgG (Vector), which was diluted  1:1,000 in 2% NGS for 2 hours.  Subsequently,  
sections were washed and reacted with Vector ABC reagent (Vector) for 30 minutes, washed 
again, and reacted with diaminobenzidine.  Stained sections were mounted on slides, dried, 
and covered with cover glass.  The specificity of immunostaining was established by using 
several approaches.  Sections were incubated as described, but without antibody  (secondary  
antisera only) or with normal rabbit serum instead of primary antibody.  Further the COX-2 
antibody was preadsorbed with 580 units of purified COX-2 (Cayman Chemical  Co., Ann 
Arbor, MI) prior to incubation with  sections.  
We used two approaches to characterize the cellular patterns in the areas examined.  First, the 
general cellular morphology was assessed by cresyl violet staining.  Second,  immunostaining  
was performed with an antibody (dilution  1:50,000) against glial fibrillary acidic protein 
(GFAP), using the same procedures as described above.  
Sections were visualized and photographed with a Zeiss Axioskop microscope (Jena,  
Germany).  Figures were created with Adobe Photoshop (San Jose, CA) software from 
original 35mm color slides and negatives, and were printed with a Fuji-x Pictograph  3000  
digital printer (Encino, CA).  Scanning contrast and intensity were altered only in order to 
replicate the original images.  The color images were converted to the gray scale by using 
filters as necessary, formatted to plate form and labeled.  
RNase protection assay (RPA) 
Total RNA was extracted in homogenization buffer (4 mol/L guanidium isocyanate, 25 
mmol/L sodium acetate, 0.1 mol/L P-mercaptoethanol).  After sonication, the homogenates 
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were transferred to phase-lock gel tubes (5-prime-3-prime, Boulder, CO).  100 pi of 2 mol/L 
sodium acetate was then added to each sample, followed by  1  ml of H20-saturated  phenol.  
After thorough mixing, 300 pi of chloroform: isoamyl alcohol (49:1) was added, and the 
solution was incubated on ice for  10 minutes before centrifugation at 6,000 rpm for 5 minutes. 
The supernatants were transferred to fresh tubes. After the addition of  1  ml of isopropanol, the 
samples were incubated at room temperature for 30 minutes and centrifuged at  12,000 rpm for 
25 minutes. The resulting pellets were washed with  100% ethanol and re-dissolved  in  
ultrapure water before storage at -60 °C.  The integrity of the RNA was determined by 
resolution in an  1% agarose gel, and RNA aliquots were quantified  spectrophotometrically.  
RPA-s were carried out on 25 pg of total RNA from each sample, using RPAII kits (Ambion, 
Austin, TX).  32P-labeled  sense and antisense probes were generated for COX-1 and COX-2 
by using MaxiScript kits (Ambion) after the linearization of  plasmids containing fragments  of  
DNA for porcine COX-1 and COX-2 (Dr. Sylvain Chemtob, Research Centre Of St. Justine 
Hospital, Montreal, Canada).  The protected fragments were resolved on 6% urea/acrylamide 
gel and autoradiographed using hyperfilm (Amersham, Arlington Heights, IL). 
Immunoblot  analysis  
Protein was extracted from frozen retinas in boiling lysis buffer (10 mmol/L Tris and  1%  
SDS).  The samples were sonicated, heated at 95 °C for 5 minutes, and centrifuged for 15 
minutes at  12,000 rpm at 4 °C.  An aliquot of the supernatant was removed for protein 
concentration determination.  After the addition of an equal volume of sample buffer (100 
mmol/L Tris, pH 6.8; 42% glycerol; 5% bromophenol blue; and  1% SDS) to each sample, the 
protein was separated on a 4-20% gradient of mini gel (Bio-Rad, NY) and transferred to 
nitrocellulose.  After nonspecific protein binding was blocked by incubating the blot in 5% 
milk, primary antibody against COX-2 (1:1000) was applied, followed by horseradish 
peroxidase-conjugated secondary antibody (1:10,000) (goat anti-rabbit,  Jackson 
Immunoresearch Labs, PA). Electrochemiluminescence  was utilized to visualize the bands. 
Molecular weight markers were also run. 
Statistical  analysis  
All numerical values are reported as means ± SD. 
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Results 
A.  COX-1  
Very little immunoreactivity  (IR-ity) for COX-1 was present in the cerebral cortex (Fig. 
1 A,C) or hippocampus (not shown) samples from the time control or untreated animals.  
Moreover, mRNA for COX-1, though detectable, was relatively low in the time control 
animals (Fig.  ID).  Detection of mRNA for COX-1 required longer times of incubation of 
gels with film than for COX-2 (compare sample versus probe lanes for COX-1 in Fig.  ID  
with those for COX-2 in Figs 9 and  13-15).  Further, the IR-ity (Fig.  IB) and mRNA levels 
(Fig.  ID) for COX-1 did not increase following anoxic stress in any region examined. 
B.  COX-2  
Immunohistochemistry 
Control conditions 
a. Cerebral cortex 
The immunolocalization of COX-2 in the erebral cortex after 8 hours in the time control 
piglets revealed widespread staining in virtually all cortical layers, but IR-ity was readily 
evident  in layers II/III, V and VI (Fig. 2A,D).  The COX-2 IR-ity throughout the layers was 
moderate and uniform in intensity; it was most evident in the pyramidal neurons of layer V 
(Fig. 2D).  Little or no cell-specific IR-ity was observed when sections were incubated with 
secondary antibody only, normal rabbit serum instead of primary antibody, or COX-2 
antibody which had been preadsorbed with purified COX-2 (Fig. 2F).  The pattern of COX-2 
IR-ity in the parietal cortex from the time control animals was nearly identical to that in the 
untreated animals (not shown). 
b.  Hippocampus  
While COX-2 IR-ity was evident in various regions, an aggregate of  subgranular,  
polymorphic neurons in the superficial hilus of the dentate gyrus consistently  displayed  
intense immunostaining in the time control samples (Fig. 3A).  Limited COX-2 IR-ity was 
also observed in the field CA3 pyramidal cells (Fig. 3B), although the intensity was more 
variable than that detected in the dentate gyrus.  Uniform and widespread COX-2 IR-ity was 
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Figure  1.  
COX-l  representation  in  cerebral  cortex.  A)  Only  a  few  neurons  (arrows)  were  immunopositive  
for COX- l  in  a  8  hour  time  control  animal.  B)  No  significant  increase  in COX- l  immunoreactivity  
was  detected  in  cortex  8  hours  after  ischemia.  C)  Higher  magnification  of  one  of  the  neurons  
shown  in  A.  COX- l  immunoreactivity  was  localized  to  the  cell  body  with  no  immunostaining  
extending  into  the  processes.  D)  RNase  Protection  Assay  showed  detectable  C O X - l  mRNA  in  time  
control  animals,  but  no  increase  in  mRNA  following  ischemia.  Long  X-ray  exposure  times  relative  
to  those  for  COX-2  blots  (see  next  figure)  were  necessary  to  detect  COX- l  mRNA  in  piglet  cortex.  
The  4,  6,  and  8  hr  time  control  lanes  are  indicated  as  C4,  C6,  and  C8,  respectively.  Likewise,  4,  6,  
and  8  hrs  after  ischemia  are  indicated  as  14,  16,  and  18,  respectively.  Unprotected  probe  digested  
with  RNase  is  shown  in  '+'  lane,  while  the  unhybridized,  undigested  probe  is  shown  in  the  '-'  lane.  
Note  that  the  unprotected  band  shown  in  the  last  lane  of  the  hippocampus  and  cerebellum  blots  
runs  at  293  bp  and  the  hybridized  bands  migrate  at  235  bp.  Bar  represents  200  pm  in  panels  A  
and  B and  25  pm  in  panel  C.  
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Figure  2.  
Effect  of  anoxic  stress  on  COX-2  immunoreactivity  in  50  pm  sections  from  cerebral  cortex.  A)  Parietal  
cortex  from  8  hr  sham  time  control  piglet  showing  uniform  COX-2  staining  primarily  in  cortical  layers  
II/III,  V,  and  VI.  Some  staining  of  smaller  cells  can  be  observed  in  the  white  matter  (W).  Roman  
numerals  indicate  cortical  layers.  B)  COX-2  immunoreactivity  was  increased  8  hrs  after  global  cerebral  
ischemia  in  cortical  layers  II/III,  V  and  VI.  Arrow  indicates  characteristic  neuron  which  can  be  seen  at  
higher  magnification  in  panel  E.  C)  Asphyxia  did  not  appear  to  alter  the  intensity  or  pattern  of  COX-2  
staining  in  parietal  cortex.  D)  Higher  magnification  of  time  control  parietal  cortex  shown  in  panel  A.  E)  
Higher  magnification  of  ischemia  parietal  cortex  shown  in  panel  B.  F) COX-2  immunoreactivity  following  
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Figure  3.  
Immunolocalization  of  COX-2  in  50  pm  sections  from  hippocampus  after  anoxic  stress.  A)  
Suprapyramidal  blade  of  the  dentate  gyrus  from  a  time  control  piglet.  COX-2  immunoreactivity  
was  consistently  observed  in  a  distinct  patch  of  neurons  in  the  polymorphic  layer  of  this  area.  B)  
The  CA3  pyramidal  layer  of  time  control  piglets  had  modest  to  low  levels  of  COX-2  
immunoreactivity.  C)  At  8  hrs  after  global  cerebral  ischemia,  COX-2  immunoreactivity  was  
observed  in  the  granule  layer  of  the  dentate  gyrus.  Concomitantly,  there  was  a  decrease  in  COX-2  
staining  of  the  polymorphic  neurons  in  this  region.  D)  An  increase  in  COX-2  immunostaining  of  
filed CA3  neurons  occurred  after  global  cerebral  ischemia.  Scale  bar  =  120  pm.  
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the hippocampal fissure (Fig. 3A,B).  The pattern of COX-2 staining in the time control 
animals was virtually identical to that in the untreated piglets (not shown). 
c.  Cerebellum  
Immunostaining for COX-2 was present at various intensities in the Purkinje cells and in the 
molecular and granular layers of the cerebellum (Fig. 4A). As in the parietal  cortex and 
hippocampus, COX-2 IR-ity was detected in both neurons and glial cells. For example, a few 
cells were consistently observed in the granular layer and most likely represented  neurons  
(Fig. 4B). Although the Purkinje cells themselves were never COX-2-positive,  small cells 
adjacent to them were immunoreactive (IR)for COX-2 and GFAP. These small cells were 
probably Bergmann glia, as suggested by double labeling against GFAP and COX-2. The thin 
processes that displayed COX-2/GAFP IR-ity in the molecular layer appeared to be mostly 
the processes of the Bergmann glia, which are known to extend to the pial surface, but some 
could also be the processes of the granule cells (Fig. 4B). 
Cellular localization of nNOS 
a.  Cortex  
Unlike COX-2, the nNOS staining in the parietal cortex was quite sparse, but was observed in 
all cortical layers (Fig. 5C). Interestingly, there did not appear to be a particular subset or 
group of cells that were nNOS-positive. Virtually no IR-ity was detected in the white matter 
(Fig. 5C). The cell-specific staining of nNOS also differed from that observed for COX-2 
(compare Fig. 5D and 5F). Very intense IR-ity was observed in the soma of large neuron-like 
cells. Moreover, the processes of these cells were IR for nNOS (Fig. 5F). As with COX-2, 
these cells are most probably neurons.  
b.  Hippocampus  
The hippocampus displayed a distinct staining pattern for nNOS (Fig. 6). Although  scattered,  
intensely labeled cells were observed throughout the hippocampus, the nNOS IR-ity was 
primarily localized to the granule cell layer of the dentate gyrus and the mossy fiber layer 
(Fig. 6A). Higher magnification of the suprapyramidal blade of the dentate gyrus region 
revealed perinuclear nNOS IR-ity in the granule cell layer and occasional IR cells in the 
polymorphic layer (Fig. 6B). However, unlike the COX-2 staining, a distinct aggregate of 
nNOS-stained cells was never observed in the subgranular layer (compare Figs 7B and 6B). In 
addition to the somal staining of the granular cells, their axons, which comprise the mossy 
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Figure  4.  
Immunolocalization  of COX-2  and  nNOS  in  cerebellum.  A)  COX-2  immunoreactivity  was  observed  
in  the  molecular  layer  (M),  Purkinje  layer(P),  and  the  granular  layer  (G).  However,  COX-2  
staining  was  never  detected  in  the  white  matter  (W).  B)  The  most  prominent  COX-2  
immunoreactivity  was  localized  to  small  cells  in  the  Purkinje  cell  layer.  These  cells  are  most  likely  
Bergmann  glia.  Note  that  the  Purkinje  cells  themselves  do  not  appear  to  be  stained  for  COX-2.  
Processes  of  the  Begmann  glia  in  the  molecular  layer  and  occasional  cells  in the granular  layer  were  
also  COX-2  positive.  C9  The  majority  of  nNOS  immunoreactivity  was  localized  to  neuron-like  
cells,  which  may  be  basket  cells,  in  the  molecular  layer.  Like  COX-2,  the  Purkinje  cells  lacked  
detectable  nNOs  immunoreactivity.  Scalebar  = 200pm  in  A;  25  pm  in  B and  C.  
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Figure  5.  
Immunolocalization  of  COX-2  and  nNOS  in  parietal  cortex.  A)  Extensive  cellular  COX-2  
immunoreactivity  was  evident  in  specially  in  cortical  layers  II/III,  V,  and  VI,  and  white  matter  (W).  
Roman  numerals  indicate  cortical  layers.  B)  Omission  of  COX-2  antibody  revealed  only  minimal  
background  immunoreactivity.  C)  Immunostaining  for nNOS  was  very  sparse  and  localized  primarly  
to  neuronal  cell  types  in  cortical  layers  II-VI.  Note  absence  of  immunoreactivity  in  white  matter.  D)  
Respresentative  photomicrograph  of  cortical  layers  II/III  showing  COX-2  immunoreactivity  licalized  
primarly  to  cell  bodies  at  various  degrees  of  intensity.  E)  COX-2  immunoreactivity  in  white  matter  
revealed  numerous  small,  multipolar  cells  projecting  stained  processes  to  adjecent  blood  vessels  
(arrow).  F)  Representative  photomicrogram  of  cortical  layers  II/III  showing  nNOS  staining  in  both  
cell  body  and  processes  of  neuron-like  cells.  Scale  bar  = 200  pm  in  A-B;  25  pm  in  D-F  
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Figure  6.  
Immunolocalization  on  nNOS  in  hippocampus.A)  Representative  cross-section  of  hippocampus  
showing  pattern  of  nNOS  immunoreactivity.  Although  occasional  nNOS  immunreactive  cells  were  
observed  throughout  the  hippocampus,  the  granular  layer  and  mossy  fiber  layer  (M)  displayed  the  
greatest  staining.  Very  few  cells  were  observed  in  the  pyramidal  cells  in  CA1  and  CA3.B)  Higher  
magnification  of  the  apical  region  of  the  dentate  gyrus.  Neuronal  NOS  immunoreactivity  appears  to  be  
localized  to  the  cell  bodies  of  the  granular  cells.  C)  Higher  magnification  of  boxed  area  in  panel  A.  
Only  occasional  pyramidal  and/or  interneurons  display  nNOS  immunoreactivity.  However,  the  mossy  
fiber  layer,wich  contains  the  axons  of  the  granular  cells,were  consistently  stained  with  nNOS.  Scale  
bar=1840  pm.  in  A,  120pm  in  B,  and  368  pm  in  C.  
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Figure  7.  
Immunolocalization  of  COX-2  in  hippocampus.  A)  Cross  section  of  hippocampus  showing  
anatomy  of  hippocampus  and  extensive  COX-2  immunoreactivity.  The  boxed  areas  indicate  the  
location  of  significant  cell  specific  COX-2  reactivity  in  several  areas,including  (B)  dentate  gyrus,  
(C)  stratum  radiatum,(D)  area  adjacent  to  the  hippocampal  sulcus,  and  (E)  CA3  pyramidal  cells.  
These  areas  are  shown  at  higher  magnification  in  panels  B-E.  B)  COX-2  immunoreactivity  was  
consistently  observed  in  the  soma  of  a  goup  of  neuron-like  cells  in  the  subgranular  region  located  
at  the  inner  tip  of  the  dentate  gyrus.  The  arrow  denotes  an  aggregate  of  these  cells.  C)  In  the  
stratum  radiatum,small,  multipolar  cells  displayed  immunoreactivity.  Often  processes  were  
observed  to  contain  areas  of  intense  COX-2  staining  (arrowheads).  D)  Numerous  small  COX-2  
staining  cells  were  located  along  the  hippocampal  sulcus  (S).  E)  Pyramidal  cells  in CA3  displayed  
various  intensities  of COX-2  immunoreactivity.  Scale  bar=  1840pm  in  A,  20  pm  in  B,  50  pm  in  C,  
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fiber layer, were also nNOS-IR (Fig. 6C).  Only occasional pyramidal cells and/or 
interneurons in this region were stained for nNOS. Interestingly, the nNOS-IR mossy fiber 
layer appeared adjacent to the CA3 pyramidal cells which are COX-2-positive (compare Figs 
7E and 6C). The distinct pattern of nNOS IR-ity appears to complement the COX-2 IR-ity in 
the dentate gyrus and theCA3 pyramidal layer of the hippocampus. 
a.  Cerebellum  
The pattern of nNOS staining in the cerebellum differed greatly from that of COX-2 (compare  
Fig. 4B and 4C). The only cells with detectable nNOS IR-ity were located in the molecular 
layer adjacent to the Purkinje cell layer (Fig. 4C). Intense nNOS IR-ity was localized to the 
cell body and the abundant processes of these cells. From morphologic considerations, the 
nNOS-stained cells in the molecular layer appear to be basket cells. 
Effect of anoxic stress on COX-2 patterns 
a. Cerebral  cortex 
Global cerebral ischemia increased the intensity of COX-2 IR-ity in the parietal  cortex  
(compare Fig. 2B and 2A).  The increase in COX-2 IR-ity occurred primarily  in the cortical 
layers which contained basal COX-2 staining (i.e. II/III, V and VI).  At higher magnification, 
the perinuclear staining of the pyramidal neurons could be observed within cortical  layers  
II/III and V (Fig. 2D (time control), and 2E (ischemia)).  COX-2 IR-ity was also evident in 
the proximal portion of the apical processes of the intensely  stained neurons (Fig. 2E).  Unlike  
ischemia, whole-body asphyxia did not appear to alter the pattern or intensity of COX-2 IR-
ity in the parietal cortex (Fig. 2C). 
Sections of the visual  cortex from a time control animal and from an animal  8 hours after the 
induction of global cerebral ischemia are shown in Fig.  8.  Preadsorption of the antisera with 
purified COX-2 before incubation with sections resulted in a low background IR-ity and no 
identifiable neuronal structures (Fig.  8B).  
The time control cortex (Fig. 8 A) contained IR COX-2 neurons located primarily in cortical 
layers II and V.  However,  some COX-2 IR neurons were scattered throughout the gray matter 
of the visual cortex, in definite layers. The neuronal COX IR-ity was increased  markedly,  
especially in cortical layers II/III and V, 8 hours after ischemia (Fig. 8B).  Increases in both 
the staining intensity of the individual neurons and the number of COX-2 IR neurons were 
apparent.  Subcellularly,  COX IR-ity filled the cytoplasm and was concentrated  in perinuclear 
26 
A 
»  ' s  
• .1 
.  •  »•  t  -.  
;  .  
r  H  ,  ,  
n 
. ¿ ' J S t ^ ,  i f  
t f i P i .  «  •  ,f  J ® ,  
IV 4  »  #  1  
*  *  
V 
VI '  " \  p  
Figure  8.  
Effects  of  ischemic  stress  on  visual  cortex  COX-2  immunoreactivity.  A)  Modest  COX-2  IR  in  
scattered  neurons  localized  to  cortical  layers  II  and  V  in  a  section  from  an  8  hour  time  control  
animal.  Roman  numerals  indicate  cortical  layers.  Insert:  Only  minimal  background  COX-2  1R  
was  seen  in section  of  visual  cortex  following  preadsorption  of COX-2  antisera  with  purified  COX-2  
antigen.  B)  Increased  COX-2  IR  was  observed  in  a section  8  hr  after  cerebral  ischemia.  The  most  
prominent  changes  in  immunoreactivity  were  in  layers  II/III,  but  an  increase  in  labeled  neurons  
also  was  prominent  in  layers  V.  Scale  bar:  100  pm.  
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Figure  9.  
Effects of indomethacin  pretretment  ( 5mg/  kg,  i.v.)  on COX-2  mRNA  in  hippocampus  
following  ischemia.  Indomethacin  pretretment  (/I) attenuated  the  large  increase  in  mRNA  
normally  seen  early  after  ischemia.  Lane  designation  are  the same  as  used  in  Figs.  13-15.  
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areas of the neuronal  soma, extending into the apical dendrite in very heavily stained neurons 
(not shown). 
b.  Hippocampus  
Global cerebral ischemia altered the pattern of COX-2 IR-ity primarily in the polymorphic 
and granule layers of the dentate gyrus and in field CA3 of Amnion's horn.  By 8 hours after 
ischemia, virtually no subgranular neurons in the polymorphic layer of the dentate were IR for 
COX-2 (Fig. 3C).  Instead, intense COX-2 IR-ity was localized to cells within the granule 
layer of the dentate gyrus (Fig. 3C).  Further, the intensity of COX-2 IR-ity in the pyramidal 
neurons in CA3 was greater and more consistent than in the time controls (Fig. 3B,D).  While  
the COX-2 IR-ity was greatly increased in both the dentate granule and the CA3 pyramidal 
layers, no detectable changes were observed in the staining of the small stellate cells 
bordering the hippocampus.  Unlike ischemia/reperfusion injury, no detectable changes in 
either the pattern or the intensity of COX-2 immunostaining were observed after whole-body 
asphyxia (not shown).  Thus, global cerebral ischemia increased not only the intensity of the 
staining in the pyramidal cells of Amnion's horn, but also the COX-2 immunostaining in the 
granule cells of the dentate gyrus. 
Indomethacin  treatment  
Systemic pretreatment with indomethacin prevented the increases in COX-2 mRNA at 2 
hours after ischemia (Fig. 9).  Indomethacin pretreatment also prevented the increases in 
COX-2 IR-ity at 8 hours after ischemia in the hippocampus (Fig.  10) and cerebral cortex (not 
shown). 
7-NI  treatment  
Systemic pretreatment with 7-NI did not prevent the increases in mRNA for COX-2 (not 
shown) following ischemia.  Further, 7-NI pretreatment had no substantial, consistent effect 
on the increases in COX-2 IR-ity at 8 hours after ischemia in the hippocampus (Fig.  11) and 
cerebral cortex (not  shown).  
COX-2 expression in the retina 
A section of retina stained with cresyl violet is shown in Fig.  12A for orientation.  From the 
outside to inward, Seven layers are discernible. From the outside inwards, these are the 
photoreceptor  (P) layer, the outer nuclear layer (ONL), the outer plexiform layer (OPL), the 
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Figure  10.  
Effects  of  indomethacin  pretreatment  (5mg/kg,  iv)  on  immunolocalization  for  PGHS-2  8  
hours  after  ischemia  on  50  pm  sections  from  hippocampus.  A:  Ischemia  increased  
PGHS-2  immunostaining  in  field  CA3  neurons  (arrows)  and  in  the  polymorphic  layer  of  
the  dentate  gyrus  (points).  B:  Indomethacin  pretreatment  completely  eliminated  
increased  immunostaining  for  PGHS-2  in  these  areas.  Original  magnification  is  3.91X  
for  A  and  3.125X  for  B.  
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Figure  11.  
Effects  of  7-NI  on  immunolocalization  for  COX-2  8  hours  after  ischemia  on  50  pm  
sections  from  hippocampus.  A)  Ischemia  alone.  B)  Ischemia  following  pretreatment  
with  7-NI  (50mg/kg,  ip  given  before  ischemia,  and  also  4  hours  after  ischemia).  There  
was  no  consistent  effect  of  7-NI  treatment  on  increases  in  COX-2  immunoreactivity  
after  ischemia.  Original  magnification  is 3.125X  for  both  A and  B.  
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Figure  12.  
Effects  of  ischemia  on  COX-2  immunoreactivity  and  immunoblotting  of  the  piglet  retina.  Panel  A  depicts  
the  laminar  organization  of the  piglet  retina  after  cresyl  violet  staining.  Labels  indicate  photoreceptor  (P),  
outer  nuclear  (ONL),  outer  plexiform  (OPL);  inner  nuclear  (INL),  inner  plexiforin  (IPL),  ganglion  cell  
(G),  and  nerve  fiber  (NFL)  layers.  Panels  B-E  indicate  retinal  sections  stained  for  COX-2.  B  and  D  are  
low  and  high  magnifications,  respectively,  of  retina  from  untreated  piglet.  Arrows  in  B and  D  represent  
relatively  heavy  COX-2  immunostaining  in  cell  bodies  within  the  INL,  which  probably  are  Miiller  cells.  
White  arrowheads  in  B indicate  presence  of COX-2  immunostaining  in OLM.  Moderate  COX-2  IR  is  also  
associated  with  layers  G  and  NFL.  Insert  in  Fig.  D demonstrates  lack  of  immunostaining  in  a  preimmune,  
control  retina.  C  and  E  are  low  and  high  magnifications,  respectively,  of  retina  from  a  piglet  12  hours  
after  ischemia.  Obvious  increases  in  COX-2  IR  occur  in  P,  OLM,  OPL/INL  interface,  G,  and  NFL.  The  
lack  of  increased  immunostaining  in  the  O N L  after  ischemia  caused  this  layer  to  appear  relatively  
unstained  as  compared  to  the  other  retinal  layers  (compare  B  and  C).  Scale  bar  100  pm  for  panels  A,  D  
and  E, 66.6  pm  for  insert  in  D, and  400  pm  for  B and  C.  
Panel  F  demonstrates  increases  in  COX-2  protein  levels  8  hours  after  ischemia  in  whole  retina  via  
immunoblotting.  The  immunoreactive  band  migrated  at  the  appropriate  molecular  weight  for  COX-2  
and  previous  studies  have  shown  that  pre-adsorption  eliminated  the  band  at  this  location.  
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inner nuclear layer (INL), the inner plexiform layer (IPL), the layer of ganglion cells (G) and 
the layer of optic nerve fibers (NFL).  A clearly discernible outer limiting membrane  (OLM) 
is also located between the ONL and P layer (Fig.  12D, arrowheads). 
Control  conditions  
Limited but detectable immunostaining for COX-2 was present in the control retinas and was 
layer-dependent.  There were no major differences in immunostaining patterns between the 
untreated and the time control retinas (data not shown).  Intact retinas immunostained for 
COX-2 are shown in Fig.  12B-E (a negative control is shown in the insert in Fig.  12D).  The  
untreated retina exhibited COX-2 IR-ity localized to the OLM (Fig.  12D, arrowheads),  with  
diffuse IR-ity throughout the ONL/OPL region.  Moderately intense staining was also evident 
in scattered areas of the ganglion cell layer and in a line of cell bodies located in the midline 
of the INL.  The location and morphology of these IR cells suggested that they were Muller 
cells. The INL staining appeared as a discontinuous chain (arrowheads) of IR-ity  coursing  
through the INL (arrows) at the lower magnification (Fig.  12B,D).  No COX-2 IR-ity above 
the background level was seen in other retinal layers.  Preimmune technical  control  sections 
of the retina revealed no detectable COX-2 IR-ity (Fig.  12D, insert). The very dark areas at 
the surface of the photoreceptor layer (most noticeable in Fig.  12B,D) are fragments of 
pigment epithelium (PE) which were still present in some sections. 
Effects of ischemia 
Ischemia induced a marked increase in COX-2 IR-ity  in the neural retina (Figs.  12C,  12E).  
After an 8 (data not shown) or  12-hour period of recovery from 10 minutes of ischemia, the 
IR COX-2 level was elevated in all layers of the retina except the ONL/OPL, with the greatest 
increases seen throughout the photoreceptor layer, including the OLM.  COX IR-ity was 
distributed in some areas along the full length of the photoreceptors into the outer  segments.  
A discontinuous row of IR COX-2 elements also became apparent after ischemia in the 
vicinity of the OPL/INL interface, which that was not seen in the untreated or time control 
retinas.  This is particularly evident in the low-magnification view in Fig.  12C.  The absence 
of significant COX-2 IR-ityin the ONL after ischemia caused this layer to appear unstained as 
compared to the increased immunoreactivity  of the other retinal  layers.  
The Muller cell COX-2 IR-ity (arrows in Fig.  12B,D) also appeared to be increasing, as 
evidenced by an increase in cytoplasmic IR-ity in. cell soma located in the midline in the INL 
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and in the basal and apical membranes, but these increases were more subtle.  Moderate to 
substantial COX IR-ity was present in the IPL, GL and NFL. 
Immunoblotting using the whole retina supported the immunostaining results  (Fig.l2F).  
Thus, the COX-2 protein level in the whole retina was increased dramatically by 8 hours after 
ischemia. 
RNase protection  assay  
Changes in COX-2 expression following anoxic stress 
Regional variations in the brain 
Global cerebral ischemia transiently increased the expression of COX-2 mRNA in the parietal 
cortex and hippocampus (Figs  13-15).  In the cerebral cortex, the upregulation of COX-2 
mRNA was variable; it occurred at 2-4 hours and returned to the control levels by 8 hours 
(Fig.  13, top; Fig.  14).  For the cortex, we converted the densities of bands into pixels, using 
the NIH Image Analysis software (version  1.55).  The densities of mRNA for cortex were 886 
± 234 pixels (mean ± standard error) for the time control animals (n=16), 3430 ± 2136 pixels 
for animals 2 hours after ischemia (n=7), 5257 ±1319 pixels for animals 4 hours after 
ischemia (n=8), and  1385 ± 33 pixels for animals 8 hours after ischemia (n=2) (P<0.05, time 
control versus 4-hour ischemia animals).  For the hippocampus, increased COX-2 mRNA 
levels occurred consistently  at 2 hour after ischemia (Fig.  13, middle; Fig.  15).  Further,  
COX-2 mRNA remained only slightly increased over the control levels at 4 and 8 hours after 
the ischemia in hippocampus.  Increases in mRNA for COX-2 occurred in other areas of the 
brain within 2-4 hours after ischemia, e.g. in the cerebellum (Fig.  13, bottom) and in the 
superior colliculus and thalamus (not shown).  Use of the sense probe for COX-2 failed to 
produce bands on the gel (Fig.  14).  
In contrast with ischemia, asphyxia did not appear to alter the COX-2 mRNA levels 
throughout the 8-hour reoxygenation period in the hippocampus (Fig.  15) or in the cerebral 
cortex or cerebellum (not shown).  Thus, the increased COX-2 mRNA synthesis appeared to 
be sensitive to the mode of anoxic stress employed. 
In the retina 
COX-2 mRNA levels were not detectable in the non-treated or time control retina at 2 hours, 
but by  1 and 2 hours after ischemia the level had increased considerably (Fig. 6).  At 4 hours 
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Figure  13.  
Upregulation  of  PGHS-2  mRNA  after  global  cerebral  ischemia.  RNase  Protection  Assay  
revealed  increased  expression  of  PGHS-2  mRNA  at  2-4  hrs  in  cerebral  cortex,  
hippocampus,  and  cerebellum.  The  2,  4,  and  8  hr  time  control  lanes  are  indicated  as  C2,  
C4,  and  C8,  respectively.  Likewise,  2,  4,  and  8  hrs  after  ischemia  are  indicated  as  12,  14,  
and  18,  respectively.  Unprotected  probe  digested  with  RNase  is  shown  in  '+'  lane,  while  
the  unhybridized,  undigested  probe  is  shown  in  the  '- '  lane.  Lane  labels  for  the  
hippocampus  and  cerebellum  blots  are  identical  to  those  of  the  cortex.  Note  that  the  
unprotected  band  shown  in  the  last  lane  of  the  hippocampus  and  cerebellum  blots  runs  at  
209  bp and  the  hybridized  bands  migrate  at  185  bp.  
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Figure  14.  
Comparison  of  bands  of  protected  fragments  of COX-2  mRNA  from  hippocampus  
run  with  anti-sense  and  sense  probes.  RNA  samples  used  with  anti-sense  and  sense  
probes  are  aliquots  from  the same  stock.  The  sense  probe  did  not  detect  mRNA.  
Lanes  as  labeled  in  figure  13.  
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Figure  15.  
Comparison  of  the  effects  of global  cerebral  ischemia  and  whole  body  asphyxia  on  
PGHS-2  mRNA  in  hippocampus.  A  transient  increase  in  PGHS-2  mRNA  occurred  
after cerebral  ischemia  while  no change  was  detected  within  4  hrs  after asphyxia.  Note  
that  there  is also very  little  difference  between  the  2  hr  time  control  band  (C2)  and  the  
untreated  band  (NT).  The  ischemia  lanes  are  indicated  by  'I'  and  asphyxia  lanes  are  
indicated  by  'A'.  The  numbers  refer  to  the  time after anoxic  stress.  The  PGHS-2  
probe  lanes  are  as  marked  in figure  2.  
RNase 




Figure  16.  
COX-2  mRNA  expression  in  the  piglet  retina  after  ischemia.  Autoradiograph  from  
Rnase  Protection  Assay  illustrates  very  low  COX  mRNA  levels  from  a  naive  control  
(NT)  and  from  a  2  hr  time  control  animal  (C2).  Expression  of  COX-2  mRNA  is  
increased  1  and  2  hrs  after  ischemia  (II  and  12).  Unhybridized  antisense  probe  
digested  with  Rnase  is  shown  in  "+"  lane,  while  unhybridized,  undigested  anti-sense  
probe  is shown  in  "-"  lane.  The  unhybridized  probe  band  shown  in  the  last  lane  runs  
at 209  bp and  the  hybridized,  protected  fragments  migrate  at  185  bp.  
RNase 
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Figure  17.  
Upregulation  of  COX-2  mRNA  in  the  visual  cortex  after  ischemia.  RNase  Protection  Assay  
revealed  increased  expression  of  COX-2  mRNA  in  the  occipital  cortex  in  animals  surviving  2  or  4  
hrs  after  ischemia  (12  and  14).  The  2  and  4  hr  time-controls  are  indicated  as  C2  and  C4.  
Unhybridized  probe  digested  with  RNase  is  shown  in  "+"  lane,  while  the  unhybridized,  
undigested  probe  is shown  in  the  "-"  lane.  
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after ischemia, the mRNA levels were not different from the  1-hour control values (data not 
shown). 
COX-2 mRNA levels were barely detectable in the untreated or time control retina at 2 hours 
in the occipital cortex (Fig.  17), but the levels increased after ischemia and peaked by 4 hours. 
In technical control experiments, no bands were evident in those lanes where total RNA 
samples were hybridized with sense riboprobes transcribed from the cDNA template (data not 
shown). 
Discussion 
Our studies have disclosed several new findings.  First, COX-2 is the predominant  COX  
isoform in the brain of the newborn pig, and COX-2 IR-ity is detectable in the retina and in 
the cerebral regions investigated.  Second, transient ischemic stress leads to enhanced  levels  
of COX-2 mRNA within 2-4 hours and of COX-2 protein within 8-12 hours. In contrast, there 
is no increase in the COX-1 mRNA and protein levels. Interestingly, the COX-2 mRNA and 
protein levels fail to increase after asphyxia. Third, indomethacin pretreatment attenuates the 
increases in COX-2 mRNA and protein levels after ischemia, whereas 7-NI pretreatment 
exerts little protective effect. 
Only a few studies have examined the localization of COX in the brains of various species. In 
general, immonohistochemical  studies indicate that COX isoforms are well represented  in the 
brains of adult monkeys (Tsubokura et al.,  1991), sheep (Breder et al.,  1992) and rats 
(Yamagata et al.,  1993; Breder et al.,  1995; Kaufmann et al.,  1996). For example,  COX-1  
displays extensive immunostaining  in the cerebral cortex and hippocampus of adult sheep and 
monkeys (Tsubokura et al.,  1991; Breder et al.,  1992). Our studies confirm and extend 
previous findings by documenting the location and extent of COX-ity within the piglet brain. 
Thus, COX-1 IR cells are barely found in the newborn brain. In contrast, a great number of 
COX-2-IR neurons and glial cells are located in the cerebral cortex, hippocampus,  cerebellum 
and retina. Similarly as in piglets, COX-2 appears to be particularly prominent in the neonatal 
rat. Further, the COX-2 protein level is predominant over that of COX-1 in the cerebral 
vasculature of the piglet (Peri et al.,  1995; Busija et al.,  1996).  Accordingly, mRNA for 
COX-2 is more abundant than COX-1 mRNA in the cerebral blood vessels (Peri et al.,  1995).  
Finally, PG production in piglet cerebral tissues and vessels is largely reduced by a selective 
COX-2 inhibitor (Peri et al.,  1995). The reason for the predominance of COX-2 in neurons 
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and glial cells in the perinatal period is unclear, but it has been suggested to be due to 
augmented synaptic activity during development (Yamagata et al.,  1993; Adams et al.,  1996;  
Kaufmann et al.,  1996).  
The immunohistochemical  characteristics of COX-2 observed in the present experiments are 
consistent with results from previous in vitro (26) and in vivo studies (14).  For example, 
COX-2 is present constitutively to varying extents in the neurons and glial cells of the 
developing central nervous system.  In addition, COX-2 is concentrated in perinuclear  areas  
and in the dendrites of the neurons and the terminal processes of the astroglia.  The changes in 
COX-2 IR are specific and do not involve all cell types, and the responses in similar cell 
populations are variable.  Finally, the increases in the COX-2 mRNA and protein levels are 
relatively rapid, occurring within a few hours. 
The COX-2 IR pattern of the control retina was such that most immunopositive  staining  
appeared in four regions, three of which are known to be associated with the Müller cell:  1) in 
a diffuse line at the level of the OLM, 2) in cell soma located in the middle of the INL, 3) in 
pockets of IR-ity between the ganglion cell nuclei, and 4) in scattered IR-ity throughout the 
ONL/OPL.  The OLM marks the apical pole of the Müller cell, a bipolar cell that spans the 
entire thickness of the retina from the basal membrane to the photoreceptor layer.  The nuclei 
of Müller cells are located within the INL, where they form a distinct median sublayer.  Thus,  
COX-2 IR was seen in areas corresponding to the Müller cell soma and at the termination of 
both outer and inner processes.  The diffuse IR-ity seen in the OPL/ONL region could be 
localized to only two cell types, photoreceptor  cell bodies which are located in the ONL, or 
the Müller cell, which at this level forms velate sheaths around the photoreceptor cell nuclei. 
Although double immunostaining for GFAP/COX-2 was not carried out, on the basis of 
location and morphological features it is likely that these IR cells are Müller cell somata.  The  
IR-ity seen at the OLM border and in the ganglionic layer is probably due to COX-2 in the 
Müller cell processes.  Little COX-2 IR was apparent in the other neuronal cell types of the 
retina  (the horizonal cell, the amacrine cell and the retinal ganglion cell), at least in the 
perinuclear areas.  
As the  physiological  evidence suggests an important functional relationship between the 
COX and NOS systems in the brain, we investigated the anatomical relationships which may 
underlie such interplay. 
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Analysis of our immunohistochemical  data showed that the nNOS patterns are distinct from 
those of COX-2 in all the brain regions investigated. The most obvious difference is that only 
a low percentage of the neurons exhibited nNOS IR-ity. This finding is similar to that 
reported in the cerebral cortex, hippocampus and cerebellum of postnatal  7-day-old rats. In 
the cerebral cortex, the nNOS immonostaining was relative sparse, but evenly  distributed,  
whereas the COX-2 IR-ity was extensive and particularly heavy in several layers. In the 
hippocampus, populations of cells immunopositive for nNOS or COX-2 were quite distinct, 
although overlap occurred in several areas, such as the CA1/CA3. Finally, the cerebellum 
nNOS and COX-2 were located in distinct cell populations. The anatomical location of nNOS 
containing cells is consistent with the possibility of an NO-modulating COX function and vice 
versa. Although there is apparently little overlap between the two cell types, the nNOS 
neurons are located close enough to affect COX-2-containing cells in the cortex, hippocampus 
or cerebellum. Although considered a relative unstable compound, NO is able to diffuse for 
considerable distances in the brain and can affect prostanoid production (Salvemini et al., 
1993; Stadler et al.,  1993; Curtis et al.,  1996; Busija,  1997; Busija and Thore,  1997). Once 
released, NO could combine with the COX-dependent  superoxide anion to form peroxynitrite 
(Beckman et al.,  1990; Beckman,  1991), which could damage adjacent cells. 
Our results confirm and extend previous findings by our own laboratories and other, 
indicating that COX-2 protein synthesis is very sensitive to ischemic stress in the piglet 
central nervous system.  Further, increased levels of COX-2 in the retina and in various 
regions of the brain will probably affect the function, maturation and susceptibility to stress in 
the nervous system, including the visual system of the developing animal. These results also 
demonstrate that the COX-2 levels are differentially affected by the type of anoxic stress, and 
that increases in COX-2 after ischemia are dependent on indomethacin- but not 7-NI-sensitive 
mechanisms. 
The attenuation of ischemia-induced increases in the COX-2 mRNA and protein levels by 
indomethacin suggests that products of the AA metabolism lead to the upregulation of COX-
2. The COX-dependent production of the superoxide anion or of prostanoids during the 
reperfusion period might activate nuclear factor (NF)-kappaB or other transcription factors 
and lead to enhanced COX-2 synthesis (Long and Pekala,  1996; Schmedtje et al.,  1997).  For  
example, indomethacin has also been reported to suppress the PGE2-induced transcription of 
corticotropin-releasing hormone (Markrigrannakis et al.,  1996).  In previous studies,  
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indomethacin pretreatment before ischemia has been shown to attenuate neuronal damage and 
to prevent increases in inducible for of heat shock protein 70 (iHSP70) and endothelial NOS 
(Beasley et al.,  1998a, b).  Thus, indomethacin may have a general effect in protecting the 
brain following ischemic stress and thereby inhibiting increases in stress-induced  proteins.  
Alternatively, by preventing the production of oxygen radicals during the reperfusion period 
(Pourcyrous et al.,1993), indomethacin pretreatment may prevent the activation of NF-kappaB 
by reactive oxygen species (Sen and Packer,  1996).  Since NO can have effects on PG 
synthesis or on the expression of COX in vitro (Salvemini et al.,  1993; Busija and Thore, 
1997; Habib et al.,  1997), it was surprising that 7-NI had minimal effects on the increases in 
COX-2 IR-ity after ischemia.  However, COX-2-immunopositive  neurons may not be 
exposed to sufficiently high levels of brain-derived NO, since there is little overlap between 
nNOS and COX-2 IR-ity in the cerebral cortex and hippocampus in piglets.  Alternatively,  
NO may be only one of many competing influences on COX-2 expression during 
ischemia/reperfusion. 
The finding that the COX-2 mRNA and protein levels in the brain increase after ischemia, but 
not after asphyxia, was unexpected because the two stimuli are equally potent in producing 
superoxide anion in piglets (Pourcyrous et al.,  1993).  Additionally, it has been found that 
iHSP 70 increases to a similar extent in the brain after either asphyxia or ischemia.  One  
possible reason for the difference in COX-2 responses between ischemia and asphyxia is that 
in the latter situation the systemic levels of C02  increase dramatically.  Vannucci  et al. (1995) 
reported that exposure to inhaled C02  is able to reduce brain damage in neonatal pups 
following hypoxia/ischemia.  In contrast, hypercapnia has been shown to enhance damage 
during ischemia in adult rats (Katsura et al.,  1994; Morimoto et al.,  1993).  Acidosis can 
suppress the activation of some (Frick et al.,  1997), but not all (Yamaji et al.,  1994)  
intermediate early genes.  Since COX-2 induction in response to hypoxia in the endothelial 
cells is dependent upon the activation of NF-kappaB (Schmedtje et al.,  1997), we speculate 
that acidosis or some other attribute of asphyxia leads to the suppression of this transcription 
factor. 
Ischemia had dramatic, but variable effects on retinal staining.  For example, the neurons and 
Muller cells exhibited enhanced COX-2 IR-ty, while the perinuclear areas of the 
photoreceptor cells showed little IR-ity.  In contrast, the changes in the COX-2 distribution in 
the retinal neuronal elements after ischemia were more dramatic.  After ischemia, a 
discontinuous line of COX-2 IR-ity was apparent at the OPL/INL interface. The dendritic 
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fields of bipolar neurons and horizontal cells are known to occupy this region, and the linear 
pattern of IR-ity might be due to increased COX-2 levels in the dendritic fields of either or 
both cell types.  The modest increases in IR-ity seen in the other synaptic regions of the retina, 
the IPL, could also be attributed to the dendritic field of other retinal neurons, the amacrine 
cells, whose somata are located in the ONL or cell bodies of the ganglion cells.  Alternatively,  
Müller cells are known to extend horizontal branches into this synaptic region. 
There are two consequences of increased COX-2 levels following ischemia in piglets.  First,  
as shown previously (Leffler et al.,  1990), the prostanoid production by the cerebral  arteries  
and tissues, is increased following ischemic stress.  Thus, prostanoid-mediated  effects on the 
cerebral circulation and/or brain function might be enhanced after ischemic stress.  Secondly,  
increased COX-2 levels would lead to enhanced superoxide anion production  during 
subsequent neurological  sequelae.  For example, seizure activity, the cessation of breathing 
and subarachnoid hemorrhage often occur following resuscitation after hypoxic/ischemic 
insults in babies (Vannucci et al.,  1995; Volpe,  1994).  The enhanced production of the 
superoxide anion under these conditions (Amstead et al.,  1989; Mirro et al.,  1989; Yamagata 
et al.,  1993; Busija and Meng,  1993; Bari et al.,  1996a) might result  in further vascular and 
neuronal damage. 
We have assessed the specificity of the COX-2 antibody and other reagents employed in 
immunostaining by using several procedures.  First, we have demonstrated  similar  
immunostaining for this and another COX-2 antibody from a different source, and use of 
either of these antibodies resulted a different staining pattern from that obtained when COX-1 
antibodies where used (Thore et al.,  1998; Domoki et al.,  1999).  Secondly,  COX-2 
immunostaining was eliminated following pre-adsorption with purified COX-2. Thirdly, the 
use of pre-immune serum or elimination of the COX-2 antibody led to minimal staining.  And  
fourthly, Western blotting on the cerebral blood vessels (Domoki et al.,  1999) confirmed the 
results from COX-2 immunostaining experiments.  In the current study, we have shown that 
Western blotting and immunohistochemistry  support the conclusion that ischemic stress 
increases the COX-2 protein levels in the retina. 
Although it has been known for decades that COX inhibitors decrease cerebral  ischemic  
injury, it has been assumed that the PG-s excerbate the damage via their effects on 
inflammation or blood flow. Treatment with a COX-2-selective inhibitor has recently been 
shown to decrease the damage after temporary focal ischemia (Nogawa et al.,  1997). Since 
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secondary hypoperfusion and inflammation are characteristic of this model, the observed 
neuroprotection could be caused by these mechanisms. However, the recent use of global 
ischemia models has yielded accumulating evidence that neuronal death in connection with 
COX-2 expression is a result of events that occur within the neuron. There are several 
pharmacological  approaches which involve the inhibition of COX or the elimination of 
specific COX metabolites, supporting this view. A major investigation of the mechanism of  
inhibited N-methyl-D-aspartate-induced  vasodilation in the brain provided evidence that COX 
-derived substances transiently disrupt the neuronal activity following anoxic stress.  The  
inhibition of COX activity results in preserved NMDA-induced vascular responses.  COX is a 
relatively unstable protein located intracellularly and it is eventually degraded during the 
metabolism of AA.  Protein synthesis is therefore required for the continued production of 
prostanoids.  On the other hand, COX is a primary source of the superoxide anion. Hence, as 
expected, the inhibition of protein synthesis also prevented ischemia-induced  suppression of 
neuronal-vascular  coupling in the cerebral cortex.  
Recent studies indicate that the AA acid metabolism plays a definite role in the mechanism of 
perinatal hypoxic brain injury. Studies of postischemic hemodynamic changes in the cerebral 
circulation revealed that the inhibition of prostanoid synthesis preserves the major vasodilator 
mechanisms (Busija,  1997). A number of data indicate that the impaired vasorelaxation is  
associated with the production and action of free radicals during the reperfusion period. The 
superoxide anion is produced in the cortex during asphyxia and reventilation in piglets 
(Pourcyrous et al.,  1993). Although there are several sources for superoxide and other free 
radicals after anoxic stress, all of them require 02 . An 0 2  load after asphyxia could enhance 
free radical production via either the mitochondrial or the arachidonate cascade. It seems that 
the COX pathway is the main source of superoxide in the brain of asphyxiated piglets  
(Pourcyrous et al.,  1993) and also in the cerebral endothelial cells (Parfenova et al.,  1997).  
The site of superoxide production is in the COX pathway when PGG2 is converted to PGH2 
(Shimizu and Wolfe,  1990). Not only does the arachidonate cascade produce oxygen free 
radicals, but these can activate the cascade. Thus, superoxide production by this mechanism 
may result in a vicious cycle of accelerating radical production, which can lead to oxidant 
injury to the cells and tissues under pathological conditions (Shimizu and Wolfe,  1990,  
Pourcyrous et al.,  1993).  
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Hypoxic/ischemic injury is a relatively common occurrence in the perinatal period, and is 
associated with immediate and sustained damage to the brain and the visual system.  Our  
findings provide a basis for suggesting that the augmented COX-2 levels observed following 
ischemic stress may participate  in the progression of these neuronal and retinal  pathological  
processes.  Nonetheless, more work is needed to establish a causative relationship between the 
increased COX-2 levels and the cellular vulnerability  in the developing brain and visual 
system. 
In conclusion, COX-2 is normally present in the retina and the various regions of the brain of 
the newborn pig, although the distribution of this enzyme is limited.  However, global 
cerebral ischemia results in increased levels of COX-2 mRNA and protein within 2-8 hours. 
The enhanced levels of COX-2 could be a major source of free radicals, and PG-s and Tx-s in 
the injured brain, and could lead to disruption of the cellular and vascular functions and 
promote injury in the retina and the brain. 
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